Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Schizophrenia
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
May 2022
Digital Magazine
Archives
Subscription
Features
Adverse Neurologic Effects of Electronic Cigarette Use
COVID-19 Impact on Pharmacists’ Mental Health and Mitigation Strategies
Insomnia Treatment Update With a Focus on Orexin Receptor Antagonists
PTA: Strep Throat
Reducing Health Inequities Through Telehealth
Stemming Community-Associated Clostridioides difficile Infection
The Pharmacist’s Role in Educating Patients About Depression
Departments
Consult Your Pharmacist
Melanoma Risk Factors and Prevention
Contemporary Compounding
Fluoxetine Hydrochloride 5 mg/g in Lipoderm Transdermal Base
Editorial
Pandemic Shifts Online Mental Health Counseling Into High Gear
Pharmacy Law
Pharmacies Must Take Steps to Protect Against Data Breaches
TrendWatch
Trends in Treatment for Mental-Health Disorders
X
May 2023
In This Issue
Digital Magazine
Archives
Subscription
Continuing Education
$7.95 Per CE Exam or $69 for 12 Lessons
Neurology, Mental Health
• May 2025
• 2.00 Credits
The Treatment of Depression in Parkinson’s Disease
• April 2025
• 2.00 Credits
Preventing and Managing Mpox
Pain Management
• March 2025
• 2.00 Credits
Tracking Illicit Opioid Trends
×
Full Image